The Tashkent Medical Academy or TMA is a public undergraduate and graduate medical school and research university based in Tashkent, Uzbekistan. The TMA is one of the oldest and largest Universities in Uzbekistan, the center of medical education and research in medicine and Life Sciences in the Republic.

During the past decade, Research Institute of Hematology and Blood Transfusion conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Research Institute of Hematology and Blood Transfusion" are "Childhood Acute Lymphoblastic Leukemia" (2 trials). Many other conditions were trialed in "Research Institute of Hematology and Blood Transfusion" in a lesser frequency.

Most popular intervention types in "Research Institute of Hematology and Blood Transfusion" are "Drug" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Daunorubicin" (2 trials), "Bortezomib" (1 trials), "Cranial irradiation" (1 trials), "Dexamethasone" (1 trials) and "Dexamethasone continuous" (1 trials). Other intervention names were less common.

The vast majority of trials in "Research Institute of Hematology and Blood Transfusion" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Research Institute of Hematology and Blood Transfusion". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Research Institute of Hematology and Blood Transfusion, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Research Institute of Hematology and Blood Transfusion, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".